Central Manchester University Hospitals, NHS Foundation Trust

Manchester M23 9LT

1 studies enrolling now · 11 studies all time

What they study most

Adrenoleukodystrophy (ALD), Arthritis, Psoriatic, Cerebral Adrenoleukodystrophy (CALD), HIV, HIV Infections, Heterozygous Familial Hypercholesterolemia, Huntington's Disease, MPS IVA, Morquio A Syndrome, Mucopolysaccharidosis IVA, Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19, Peanut Allergy

Studies at this site

• Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort — Recruiting now
• A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease — Running, not enrolling
• A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults — Completed
• PALISADE Follow-on Study (ARC004) — Completed
• Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adults (PALISADE) — Completed
• Observational Study to Evaluate Allogeneic HSCT Outcomes for Cerebral Adrenoleukodystrophy (CALD) — Stopped early
• Open-label Safety Study of E/C/F/TAF (Genvoya®) in HIV-1 Positive Patients With Mild to Moderate Renal Impairment — Completed
• Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Study Of PF-04447943, Co-Administered With And Without Hydroxyurea, In Subjects With Stable Sickle Cell Disease — Completed
• Randomized, Placebo Controlled Study Of The Efficacy And Safety Of PF-02545920 In Subjects With Huntington's Disease — Completed
• A 52 Week Study To Assess The Use Of Bococizumab (PF-04950615; RN316) In Subjects With Heterozygous Familial Hypercholesterolemia — Completed
• Efficacy and Safety Study of BMN 110 for Morquio A Syndrome Patients Who Have Limited Ambulation — Stopped early